GlassScriptPhysician profile
David A Stroh
NPI 1518232875
$6,157.06
in general payments reported to CMS, 2019-2025
7 companies · $1,784 in 2025
The $1,784 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $511 · 2021: $173 · 2022: $839 · 2023: $552 · 2024: $2,299 · 2025: $1,784.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,372 · Food and Beverage: $2,262.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,372.30 |
| Food and Beverage | $2,262.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $5,487.80 | 2019-2025 | Gamma, Valor, Pro |
| Medical Device Business Services, INC. | $250.00 | 2019 | |
| Depuy Synthes Sales INC. | $175.97 | 2022-2025 | Na |
| Si-Bone, INC. | $136.61 | 2021-2024 | |
| Smith+Nephew, INC. | $67.60 | 2021-2022 | |
| Integra Lifesciences Corporation | $24.97 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Kerecis Limited | $14.11 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Stroh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.